Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirikizumab vs Azathioprine in Newly Diagnosed Crohn's Disease
NCT07659353Phase 4Not yet recruiting
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Aug 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 4 trial of mirikizumab in Crohn's disease, sponsored by Universitätsklinikum Schleswig-Holstein. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
mirikizumab
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT07659353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07659353.